By Drug Target Review2025-10-29T10:28:41
Scientists have identified an overactive brain cell type linked to schizophrenia-like symptoms in mice – a discovery that could lead to new, targeted treatments to prevent cognitive impairments.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-31T14:05:00Z
2026-03-30T09:54:00Z
2023-01-19T15:38:17
Sponsored by Cell Signaling Technology
2025-07-30T08:00:00
Sponsored by Wuxi Biologics
2023-07-04T10:05:58
Sponsored by Revvity
2024-01-19T07:40:55
Sponsored by Euretos
2023-05-23T11:10:47
Sponsored by NanoTemper Technologies
2023-02-07T15:25:20
Sponsored by Bio-Techne
Site powered by Webvision Cloud